TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy. [electronic resource]
Producer: 20170710Description: 112-120 p. digitalISSN:- 1600-065X
- Animals
- Antibodies, Monoclonal -- therapeutic use
- Antigens, CD -- immunology
- Antigens, Differentiation, T-Lymphocyte -- metabolism
- CTLA-4 Antigen -- immunology
- Humans
- Immunotherapy -- methods
- Killer Cells, Natural -- immunology
- Lymphocyte Activation
- Neoplasms -- immunology
- Programmed Cell Death 1 Receptor -- immunology
- Receptors, Immunologic -- immunology
- Signal Transduction
- T-Lymphocytes -- immunology
- Tumor Escape
- T Lineage-Specific Activation Antigen 1
No physical items for this record
Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.